Calabasas, California
United States
6
2019-12-26
6
2022-11-29
These are the the leading inventors for applications assigned to ARMAGEN, INC.:
ARMAGEN, INC. based in Calabasas, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Methods and compositions for increasing alpha-L-iduronidase activity in the CNS
#2 | 2019-06-20 ✅ Patent 11,028,156 granted on 2021-06-08Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS
#3 | 2017-04-27 ✅ Patent 10,202,467 granted on 2019-02-12Methods and compositions for increasing α-L-iduronidase activity in the CNS
#4 | 2016-07-21 ✅ Patent 10,538,589 granted on 2020-01-21Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU
#5 | 2015-07-23 ✅ Patent 11,155,631 granted on 2021-10-26Macromolecular compositions that cross the blood-brain barrier and methods of use thereof
#6 | 2014-09-25 ✅ Patent 10,144,783 granted on 2018-12-04Macromolecular compositions that cross the blood-brain barrier and methods of use thereof
Also check out ARMAGEN, INC.'s (Calabasas, United States) applicant profile with 7 patent applications submitted.
390765 ⎘